{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:38:09Z","timestamp":1788907089596,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:00:00Z","timestamp":1605571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Dermatol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Antibiotics have been used for decades against <jats:italic>Cutibacterium acnes<\/jats:italic> (previously known as <jats:italic>Propionibacterium acnes; C. acnes)<\/jats:italic>. Alarmingly, antibiotic resistance to this bacterium has become a worldwide problem in recent years. No studies are available on the antibiotic susceptibility patterns of <jats:italic>C. acnes<\/jats:italic> among Jordanian acne patients and how that is influenced by antibiotic use.<\/jats:p>\n<jats:p>This study aims to assess antibiotic resistance patterns of <jats:italic>C. acnes<\/jats:italic> clinical isolates and neighboring Gram-positive normal flora of the skin obtained from acne patients attending dermatology clinics in Amman \u2013Jordan appraising the role of antibiotic consumption.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>This is a cross-sectional study of acne patients presenting to selected dermatology outpatient clinics over a 6-month study period. Swabs obtained from inflamed lesions were cultured aerobically and anaerobically. Isolates were identified and screened for antibiotic susceptibility. In addition, all patients were asked to fill in a questionnaire that included questions about the history of antibiotic treatment.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p><jats:italic>C. acnes<\/jats:italic> was isolated from lesions of 100 patients out of 115 participants included in this study. 73% of the isolates were resistant to erythromycin and 59% to clindamycin 37% to doxycycline, 36% to tetracycline, 31% to trimethoprim \/ sulfamethoxazole, 15% to levofloxacin, and 3% to minocycline. Multi drug resistance (MDR) in <jats:italic>C. acnes<\/jats:italic> isolates as well as <jats:italic>Staphylococcus aureus<\/jats:italic> (<jats:italic>S. aureus<\/jats:italic>) and <jats:italic>Staphylococcus epidermidis (S. epidermidis<\/jats:italic>) with a similar pattern of resistance were detected from the same patient in most cases. A pattern of higher resistance towards variable antibiotic was observed in patients previously treated with antibiotics for acne management.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>The findings of this study demonstrate the distribution of antibiotic resistance of <jats:italic>C. acnes<\/jats:italic> towards used antibiotics and emphasizes the influence of antibiotic consumption on development of antibiotic resistance. The similar pattern of resistance between skin bacteria tested in this study highlights the genetic transfer of resistance between skin commensals including <jats:italic>S. aureus<\/jats:italic> and <jats:italic>S. epidermidis<\/jats:italic> hence promoting its circulation in the community.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12895-020-00108-9","type":"journal-article","created":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T16:03:03Z","timestamp":1605628983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":69,"title":["Antibiotic resistant Cutibacterium acnes among acne patients in Jordan: a cross sectional study"],"prefix":"10.1186","volume":"20","author":[{"given":"Eman","family":"Alkhawaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleem","family":"Hammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medhat","family":"Abdelmalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naser","family":"Mahasneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayan","family":"Alkhawaja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5401-6532","authenticated-orcid":false,"given":"Suzanne M.","family":"Abdelmalek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"108_CR1","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/bjd.12149","volume":"168","author":"K Bhate","year":"2013","unstructured":"Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168:474\u201385. https:\/\/doi.org\/10.1111\/bjd.12149.","journal-title":"Br J Dermatol"},{"key":"108_CR2","first-page":"231","volume":"17","author":"N Ahmad","year":"2007","unstructured":"Ahmad N, Niazi K. Beliefs and perceptions about acne among undergraduate medical students. J Pakistan Assoc Dermatologists. 2007;17:231\u20134.","journal-title":"J Pakistan Assoc Dermatologists"},{"issue":"5 Suppl","key":"108_CR3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaad.2009.01.019","volume":"60","author":"D Thiboutot","year":"2009","unstructured":"Thiboutot D, Gollnick H, Bettoli V, Dr\u00e9no B, Kang S, Leyden JJ, et al. New insights into the management of acne: an update from the global Alliance to improve outcomes in acne group. J Am Acad Dermatol. 2009;60(5 Suppl):S1\u201350.","journal-title":"J Am Acad Dermatol"},{"key":"108_CR4","first-page":"361","volume-title":"Acne vulgaris","author":"HC Williams","year":"2012","unstructured":"Williams HC, Dellavalle RP, Garner S. Acne vulgaris. In: The Lancet. Elsevier; 2012. p. 361\u201372."},{"issue":"SUPPL. 1","key":"108_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-3083.2011.04374.x","volume":"26","author":"A Nast","year":"2012","unstructured":"Nast A, Dr\u00e9no B, Bettoli V, Degitz K, Erdmann R, Finlay AY, et al. European evidence-based (S3) guidelines for the treatment of acne. J Eur Acad Dermatol Venereol. 2012;26(SUPPL. 1):1\u201329.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"108_CR6","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s13555-019-00320-7","volume":"9","author":"N Zhang","year":"2019","unstructured":"Zhang N, Yuan R, Xin KZ, Lu Z, Ma Y. Antimicrobial Susceptibility, Biotypes and Phylotypes of Clinical Cutibacterium (Formerly Propionibacterium) acnes Strains Isolated from Acne Patients: An Observational Study. Dermatol Ther (Heidelb). 2019;9:735\u201346. https:\/\/doi.org\/10.1007\/s13555-019-00320-7.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"108_CR7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1111\/j.1365-2133.2008.08437.x","volume":"158","author":"AL Cogen","year":"2008","unstructured":"Cogen AL, Nizet V, Gallo RL. Skin microbiota: a source of disease or defence? Br J Dermatol. 2008;158:442\u201355.","journal-title":"Br J Dermatol"},{"key":"108_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/jdv.12224","volume":"28","author":"C Beylot","year":"2014","unstructured":"Beylot C, Auffret N, Poli F, Claudel JP, Leccia MT, Del Giudice P, et al. Propionibacterium acnes: an update on its role in the pathogenesis of acne. J Eur Acad Dermatol Venereol. 2014;28:271\u20138.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"108_CR9","first-page":"734","volume":"86","author":"S Titus","year":"2012","unstructured":"Titus S, Hodge J. Diagnosis and treatment of acne. Am Fam Physician. 2012;86:734\u201340.","journal-title":"Am Fam Physician"},{"key":"108_CR10","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1586\/17469872.1.1.165","volume":"1","author":"MC Pires","year":"2006","unstructured":"Pires MC, de Souza Sittart JA. Systemic antibiotics in acne. Expert Rev Dermatol. 2006;1:165\u20137.","journal-title":"Expert Rev Dermatol"},{"issue":"2 Suppl","key":"108_CR11","first-page":"4","volume":"83","author":"F Ghali","year":"2009","unstructured":"Ghali F, Kang S, Leyden J, Shalita AR, Thiboutot DM. Changing the face of acne therapy. Cutis. 2009;83(2 Suppl):4\u201315.","journal-title":"Cutis"},{"key":"108_CR12","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1111\/jdv.12057","volume":"27","author":"NS a Abdel Fattah","year":"2013","unstructured":"Abdel Fattah NS a, Darwish YW. In vitro antibiotic susceptibility patterns of Propionibacterium acnes isolated from acne patients: an Egyptian university hospital-based study. J Eur Acad Dermatol Venereol. 2013;27:1546\u201351.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"108_CR13","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/S1473-3099(15)00527-7","volume":"16","author":"TR Walsh","year":"2016","unstructured":"Walsh TR, Efthimiou J, Dr\u00e9no B. Systematic review of antibiotic resistance in acne: an increasing topical and oral threat. Lancet Infect Dis. 2016;16:e23\u201333.","journal-title":"Lancet Infect Dis"},{"key":"108_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/00015550310016463","volume":"83","author":"U Jappe","year":"2003","unstructured":"Jappe U. Pathological mechanisms of acne with special emphasis on Propionibacterium acnes and related therapy. Acta Derm Venereol. 2003;83:241\u20138.","journal-title":"Acta Derm Venereol"},{"key":"108_CR15","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1001\/archdermatol.2011.67","volume":"147","author":"M Fanelli","year":"2011","unstructured":"Fanelli M, Kupperman E, Lautenbach E, Edelstein PH, Margolis DJ. Antibiotics, acne, and Staphylococcus aureus colonization. Arch Dermatol. 2011;147:917\u201321.","journal-title":"Arch Dermatol"},{"key":"108_CR16","first-page":"833","volume-title":"Antibiotic resistance of microbial strains isolated from Korean acne patients","author":"SH Moon","year":"2012","unstructured":"Moon SH, Roh HS, Kim YH, Kim JE, Ko JY. Antibiotic resistance of microbial strains isolated from Korean acne patients; 2012. p. 833\u20137."},{"key":"108_CR17","volume-title":"Determination of microbial agents of acne vulgaris and Propionibacterium acnes antibiotic resistance in patients referred to dermatology clinics in Kerman, Iran","author":"S Zandi","year":"2011","unstructured":"Zandi S, Vares B, Abdollahi H. Determination of microbial agents of acne vulgaris and Propionibacterium acnes antibiotic resistance in patients referred to dermatology clinics in Kerman, Iran; 2011."},{"key":"108_CR18","volume-title":"Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard-Twelfth Edition. M02-A12. 950 West Valley Road, Suite 2500 Wayne, PA 19087 USA","author":"National Committee for Clinical Laboratory Standards","year":"2015","unstructured":"National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard-Twelfth Edition. M02-A12. 950 West Valley Road, Suite 2500 Wayne, PA 19087 USA; 2015. www.clsi.org."},{"key":"108_CR19","unstructured":"Ramos-e-Silva M, Carneiro SC. Acne vulgaris: review and guidelines. Dermatol Nurs. 2009;21."},{"key":"108_CR20","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1001\/archderm.139.7.897","volume":"139","author":"A Chiu","year":"2003","unstructured":"Chiu A, Chon SY, Kimball AB. The Response of Skin Disease to Stress. Arch Dermatol. 2003;139:897\u2013900.","journal-title":"Arch Dermatol"},{"key":"108_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2340\/00015555-0231","volume":"87","author":"G Yosipovitch","year":"2007","unstructured":"Yosipovitch G, Tang M, Dawn AG, Chen M, Goh CL, Chan YH, et al. Study of psychological stress, sebum production and acne vulgaris in adolescents. Acta Derm Venereol. 2007;87:135\u20139.","journal-title":"Acta Derm Venereol"},{"key":"108_CR22","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.clindermatol.2004.03.004","volume":"22","author":"CC Zouboulis","year":"2004","unstructured":"Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol. 2004;22:360\u20136.","journal-title":"Clin Dermatol"},{"key":"108_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3201\/eid0702.010204","volume":"7","author":"HF Chambers","year":"2001","unstructured":"Chambers HF. The changing epidemiology of Staphylococcus aureus? Emerg Infect Dis. 2001;7:178\u201382.","journal-title":"Emerg Infect Dis"},{"key":"108_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1159\/000499858","volume":"235","author":"JP Claudel","year":"2019","unstructured":"Claudel JP, Auffret N, Leccia MT, Poli F, Corvec S, Dr\u00e9no B. Staphylococcus epidermidis: a potential new player in the physiopathology of acne? Dermatology. 2019;235:287\u201394.","journal-title":"Dermatology."},{"key":"108_CR25","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00253-013-5394-8","volume":"98","author":"Y Wang","year":"2014","unstructured":"Wang Y, Kuo S, Shu M, Yu J, Huang S, Dai A, et al. Staphylococcus epidermidis in the human skin microbiome mediates fermentation to inhibit the growth of Propionibacterium acnes: implications of probiotics in acne vulgaris. Appl Microbiol Biotechnol. 2014;98:411\u201324.","journal-title":"Appl Microbiol Biotechnol"},{"key":"108_CR26","doi-asserted-by":"crossref","unstructured":"Coates P, Vyakrnam S, Eady EA, Jones CE, Cove JH, Cunliffe WJ. Clinical Investigations Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients : 10-year surveillance data and snapshot distribution study. Br J Dermatol. 2002:840\u20138.","DOI":"10.1046\/j.1365-2133.2002.04690.x"},{"key":"108_CR27","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1111\/j.1468-3083.2008.02890.x","volume":"22","author":"PJ Magin","year":"2008","unstructured":"Magin PJ, Pond CD, Smith WT, Watson AB, Goode SM. A cross-sectional study of psychological morbidity in patients with acne, psoriasis and atopic dermatitis in specialist dermatology and general practices. J Eur Acad Dermatology Venereol. 2008;22:1435\u201344.","journal-title":"J Eur Acad Dermatology Venereol"},{"key":"108_CR28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1046\/j.1365-2133.2003.05067.x","volume":"148","author":"JI Ross","year":"2003","unstructured":"Ross JI, Snelling AM, Carnegie E, Coates P, Cunliffe WJ, Bettoli V, et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol. 2003;148:467\u201378. https:\/\/doi.org\/10.1046\/j.1365-2133.2003.05067.x.","journal-title":"Br J Dermatol"},{"issue":"PART 5","key":"108_CR29","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1099\/jmm.0.067611-0","volume":"63","author":"K Nakase","year":"2014","unstructured":"Nakase K, Nakaminami H, Takenaka Y, Hayashi N, Kawashima M, Noguchi N. Relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan. J Med Microbiol. 2014;63(PART 5):721\u20138. https:\/\/doi.org\/10.1099\/jmm.0.067611-0.","journal-title":"J Med Microbiol"},{"key":"108_CR30","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/jac\/49.1.165","volume":"49","author":"JI Ross","year":"2002","unstructured":"Ross JI, Carnegie E, Cove JH. Detection of transposon Tn5432-mediated macrolide-lincosamide-streptogramin B (MLSB) resistance in cutaneous propionibacteria from six European cities. - abstract - Europe PMC. J Antimicrob Chemother. 2002;49:165\u20138 https:\/\/europepmc.org\/article\/med\/11751782. Accessed 8 May 2020.","journal-title":"J Antimicrob Chemother"},{"key":"108_CR31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1136\/bmj.39048.540394.BE","volume":"334","author":"P McManus","year":"2007","unstructured":"McManus P, Iheanacho I. Don\u2019t use minocycline as first line oral antibiotic in acne. BMJ. 2007;334:154.","journal-title":"BMJ."},{"key":"108_CR32","first-page":"1","volume":"17","author":"S Humphrey","year":"2012","unstructured":"Humphrey S. Antibiotic resistance in acne treatment. Skin Therapy Lett. 2012;17:1\u20133.","journal-title":"Skin Therapy Lett"},{"key":"108_CR33","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.2165\/00003495-200464210-00002","volume":"64","author":"B Dreno","year":"2004","unstructured":"Dreno B. Topical antibacterial therapy for acne vulgaris. Drugs. 2004;64:2389\u201397.","journal-title":"Drugs."},{"key":"108_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.anaerobe.2004.02.002","volume":"10","author":"C Oprica","year":"2004","unstructured":"Oprica C, Emtestam L, Lapins J, Borglund E, Nyberg F, Stenlund K, et al. Antibiotic-resistant Propionibacterium acnes on the skin of patients with moderate to severe acne in Stockholm. Anaerobe. 2004;10:155\u201364.","journal-title":"Anaerobe."},{"key":"108_CR35","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/j.1365-4632.2011.05371.x","volume":"52","author":"F Schafer","year":"2013","unstructured":"Schafer F, Fich F, Lam M, G\u00e1rate C, Wozniak A, Garcia P. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne. Int J Dermatol. 2013;52:418\u201325. https:\/\/doi.org\/10.1111\/j.1365-4632.2011.05371.x.","journal-title":"Int J Dermatol"},{"key":"108_CR36","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/S0025-6196(12)62479-3","volume":"66","author":"JD Smilack","year":"1991","unstructured":"Smilack JD, Wilson WR, Cockerill FR. Tetracyclines, chloramphenicol, erythromycin, clindamycin, and metronidazole. Mayo Clin Proc. 1991;66:1270\u201380.","journal-title":"Mayo Clin Proc"}],"container-title":["BMC Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12895-020-00108-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12895-020-00108-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12895-020-00108-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T16:06:14Z","timestamp":1605629174000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcdermatol.biomedcentral.com\/articles\/10.1186\/s12895-020-00108-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["108"],"URL":"https:\/\/doi.org\/10.1186\/s12895-020-00108-9","relation":{},"ISSN":["1471-5945"],"issn-type":[{"value":"1471-5945","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,17]]},"assertion":[{"value":"5 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}